Clinical trial
Clinical Study of Ovarian Injection of Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response
NCT05105724 is registered in ClinicalTrials.gov with Nanjing University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Ovarian Injection of Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response
- Lead sponsor
- Nanjing University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 20, 2019
- Completion date
- July 20, 2022
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.